The Eindhoven neurotechnology company is using the proceeds to fund its Empower BP pivotal trial, which tests whether its implantable ARC-IM® system can treat blood pressure instability after spinal cord injury, while expanding commercial rollout of its already-cleared ARC-EX® external therapy syste
⚡
Key Insights
10 AI-generated analytical points · Not copied from source
A
Ana-Maria Stanciuc
📡
Deep Analysis
Original editorial research · AiFeed24 Intelligence Desk
✦ AiFeed24 Original
Multi-Source Intelligence
AI-synthesized from 5-10 independent sources
Fact Check
Multi-source verificationFound this useful? Share it!
Read the Full Story
Continue reading on The Next Web
Related Stories
💻Technology
Cyberpunk platformers, gallivanting geckos and other new indie games worth checking out
1 day ago
💻Technology
A comet gets destroyed by the sun, data centers endanger the Potomac River, and more science news
about 22 hours ago
💻Technology
DOJ refuses to help French authorities in criminal probe of X
about 22 hours ago
💻Technology
Apple avoids a second import ban for its redesigned smartwatches in latest court ruling
about 20 hours ago